These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 35111651)

  • 21. Comparison of biparametric and multiparametric MRI in the diagnosis of prostate cancer.
    Xu L; Zhang G; Shi B; Liu Y; Zou T; Yan W; Xiao Y; Xue H; Feng F; Lei J; Jin Z; Sun H
    Cancer Imaging; 2019 Dec; 19(1):90. PubMed ID: 31864408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of Prostate Cancer in PI-RADS Version 2.1 Transition Zone Atypical Nodules Upgraded by Abnormal DWI: Correlation With MRI-Directed TRUS-Guided Targeted Biopsy.
    Lim CS; Abreu-Gomez J; Carrion I; Schieda N
    AJR Am J Roentgenol; 2021 Mar; 216(3):683-690. PubMed ID: 32755208
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical implementation of magnetic resonance imaging guided adaptive radiotherapy for localized prostate cancer.
    Tetar SU; Bruynzeel AME; Lagerwaard FJ; Slotman BJ; Bohoudi O; Palacios MA
    Phys Imaging Radiat Oncol; 2019 Jan; 9():69-76. PubMed ID: 33458428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterizing local dose perturbations due to gas cavities in magnetic resonance-guided radiotherapy.
    Shortall J; Vasquez Osorio E; Chuter R; Green A; McWilliam A; Kirkby K; Mackay R; van Herk M
    Med Phys; 2020 Jun; 47(6):2484-2494. PubMed ID: 32144781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostate Indeterminate Lesions on Magnetic Resonance Imaging-Biopsy Versus Surveillance: A Literature Review.
    Gómez Rivas J; Giganti F; Álvarez-Maestro M; Freire MJ; Kasivisvanathan V; Martinez-Piñeiro L; Emberton M
    Eur Urol Focus; 2019 Sep; 5(5):799-806. PubMed ID: 29525382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. First prospective clinical evaluation of feasibility and patient acceptance of magnetic resonance-guided radiotherapy in Germany.
    Klüter S; Katayama S; Spindeldreier CK; Koerber SA; Major G; Alber M; Akbaba S; Debus J; Hörner-Rieber J
    Strahlenther Onkol; 2020 Aug; 196(8):691-698. PubMed ID: 32002567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostate Imaging-Reporting and Data System Steering Committee: PI-RADS v2 Status Update and Future Directions.
    Padhani AR; Weinreb J; Rosenkrantz AB; Villeirs G; Turkbey B; Barentsz J
    Eur Urol; 2019 Mar; 75(3):385-396. PubMed ID: 29908876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biparametric MRI of the prostate.
    Scialpi M; D'Andrea A; Martorana E; Malaspina CM; Aisa MC; Napoletano M; Orlandi E; Rondoni V; Scialpi P; Pacchiarini D; Palladino D; Dragone M; Di Renzo G; Simeone A; Bianchi G; Brunese L
    Turk J Urol; 2017 Dec; 43(4):401-409. PubMed ID: 29201499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An update on prostate biopsy in the era of magnetic resonance imaging.
    Cicione A; De Nunzio C; Manno S; Damiano R; Posti A; Lima E; Tubaro A; Balloni F
    Minerva Urol Nefrol; 2018 Jun; 70(3):264-274. PubMed ID: 29595039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiparametric (mp) MRI of prostate cancer.
    Kumar V; Bora GS; Kumar R; Jagannathan NR
    Prog Nucl Magn Reson Spectrosc; 2018 Apr; 105():23-40. PubMed ID: 29548365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Update on the ICUD-SIU consultation on multi-parametric magnetic resonance imaging in localised prostate cancer.
    Barret E; Turkbey B; Puech P; Durand M; Panebianco V; Fütterer JJ; Renard-Penna R; Rouvière O
    World J Urol; 2019 Mar; 37(3):429-436. PubMed ID: 30003373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MRI-LINAC: A transformative technology in radiation oncology.
    Ng J; Gregucci F; Pennell RT; Nagar H; Golden EB; Knisely JPS; Sanfilippo NJ; Formenti SC
    Front Oncol; 2023; 13():1117874. PubMed ID: 36776309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeted MRI/TRUS fusion-guided biopsy in men with previous prostate biopsies using a novel registration software and multiparametric MRI PI-RADS scores: first results.
    Tewes S; Hueper K; Hartung D; Imkamp F; Herrmann TR; Weidemann J; Renckly S; Kuczyk MA; Wacker F; Peters I
    World J Urol; 2015 Nov; 33(11):1707-14. PubMed ID: 25774003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High Diagnostic Performance of Short Magnetic Resonance Imaging Protocols for Prostate Cancer Detection in Biopsy-naïve Men: The Next Step in Magnetic Resonance Imaging Accessibility.
    van der Leest M; Israël B; Cornel EB; Zámecnik P; Schoots IG; van der Lelij H; Padhani AR; Rovers M; van Oort I; Sedelaar M; Hulsbergen-van de Kaa C; Hannink G; Veltman J; Barentsz J
    Eur Urol; 2019 Nov; 76(5):574-581. PubMed ID: 31167748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can Clinically Significant Prostate Cancer Be Detected with Multiparametric Magnetic Resonance Imaging? A Systematic Review of the Literature.
    Fütterer JJ; Briganti A; De Visschere P; Emberton M; Giannarini G; Kirkham A; Taneja SS; Thoeny H; Villeirs G; Villers A
    Eur Urol; 2015 Dec; 68(6):1045-53. PubMed ID: 25656808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective comparison of a fast 1.5-T biparametric with the 3.0-T multiparametric ESUR magnetic resonance imaging protocol as a triage test for men at risk of prostate cancer.
    Van Nieuwenhove S; Saussez TP; Thiry S; Trefois P; Annet L; Michoux N; Lecouvet F; Tombal B
    BJU Int; 2019 Mar; 123(3):411-420. PubMed ID: 30240059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic Accuracy of Single-plane Biparametric and Multiparametric Magnetic Resonance Imaging in Prostate Cancer: A Randomized Noninferiority Trial in Biopsy-naïve Men.
    Russo F; Mazzetti S; Regge D; Ambrosini I; Giannini V; Manfredi M; De Luca S; Bollito E; Porpiglia F
    Eur Urol Oncol; 2021 Dec; 4(6):855-862. PubMed ID: 33893066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Magnetic resonance imaging in prostate cancer detection and management: a systematic review.
    Monni F; Fontanella P; Grasso A; Wiklund P; Ou YC; Randazzo M; Rocco B; Montanari E; Bianchi G
    Minerva Urol Nefrol; 2017 Dec; 69(6):567-578. PubMed ID: 28488844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostate cancer detection on transrectal ultrasonography-guided random biopsy despite negative real-time magnetic resonance imaging/ultrasonography fusion-guided targeted biopsy: reasons for targeted biopsy failure.
    Cash H; Günzel K; Maxeiner A; Stephan C; Fischer T; Durmus T; Miller K; Asbach P; Haas M; Kempkensteffen C
    BJU Int; 2016 Jul; 118(1):35-43. PubMed ID: 26384851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MR-guidance in clinical reality: current treatment challenges and future perspectives.
    Corradini S; Alongi F; Andratschke N; Belka C; Boldrini L; Cellini F; Debus J; Guckenberger M; Hörner-Rieber J; Lagerwaard FJ; Mazzola R; Palacios MA; Philippens MEP; Raaijmakers CPJ; Terhaard CHJ; Valentini V; Niyazi M
    Radiat Oncol; 2019 Jun; 14(1):92. PubMed ID: 31167658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.